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DObjective: Controversy exists regarding the perioperative renal effects of off-pump versus on-pump coronary
artery bypass grafting. Large case-matched and randomized comparisons have shown conflicting results. This
study focuses on this clinical controversy.
Methods:We studied 5589 consecutive patients from a single center who underwent off-pump or on-pump cor-
onary artery bypass grafting between 2002 and 2010. All preoperative, intraoperative, and postoperative data
were prospectively collected. Patients were matched by using a nearest neighbor matching estimation method
for average treatment effects, with bias correction (Stata 11.2, StataCorp, College Station, Tex). The matching
characteristics were age, gender, body mass index, hypertension, diabetes, peripheral vascular disease, cerebro-
vascular disease, left ventricular grade, preoperative serum creatinine, operative priority, and Cardiac Anesthesia
Risk Evaluation score.
Results: The mean patient age was 64.9  10.0 years, and 4387 (78.5%) were male. Mean calculated preop-
erative creatinine clearancewas 82.0 32.6 mL/min. Perioperativemortality was 1.5%with off-pump coronary
artery bypass grafting and 1.7% with on-pump coronary artery bypass grafting (P ¼ .6). The mean change in
creatinine clearance, from the preoperative value to the lowest postoperative value, was6.3  14.1 mL/min
with off-pump coronary artery bypass grafting versus5.0 15.5 mL/min with on-pump coronary artery bypass
grafting (P ¼ .06). After matching, patients undergoing off-pump coronary artery bypass grafting had a greater
creatinine increase and greater loss of creatinine clearance postoperatively compared with patients undergoing
on-pump coronary artery bypass grafting (both P<.05). Requirements for de novo postoperative dialysis were
equivalent at 2.6% in off-pump coronary artery bypass grafting versus 2.1% in on-pump coronary artery bypass
grafting (P ¼ .4). Median postoperative hospital stay was 8 days in both groups (P ¼ .8).
Conclusions:Off-pump coronary artery bypass grafting does not preserve renal function to a greater extent than
on-pump coronary artery bypass grafting. In fact, a trend to the reverse exists with no clinically harmful effects.
(J Thorac Cardiovasc Surg 2012;143:85-92)When compared with conventional on-pump coronary
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With regard to renal function, data on the effects of OP-
CAB versus on-pump CABG on postoperative renal impair-
ment have been controversial. Some studies indicated that
OPCAB was not associated with reduced renal morbidity,4
whereas others suggested that OPCAB decreases the risk
of renal impairment after bypass surgery.5,6 However,
available studies thus far did not include a large number of
patients or did not allow for comparisons that accounted
for important and prospectively captured covariates, which
could affect the hemodynamic, inflammatory, and renal
outcomes of the patients.7
The present study aimed at comparing the renal outcomes
of OPCAB with that of on-pump CABG in a large, prospec-
tive series. To this end, we used multivariable and nearest
neighbor case-matched observational study analyses, by
which the outcomes of 5039 patients who underwentardiovascular Surgery c Volume 143, Number 1 85
Abbreviations and Acronyms
CABG ¼ coronary artery bypass grafting
CARE ¼ Cardiac Anesthesia Risk Evaluation
OPCAB ¼ off-pump coronary artery bypass
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Don-pumpCABGwere compared with that of 550 contempo-
rary patients who underwent OPCAB.MATERIALS AND METHODS
Patient Groups
The on-pump CABG group in this study includes 5039 consecutive pa-
tients who underwent on-pump, first-time CABG, performed by any 1 of 10
surgeons (with a maximum of 8 surgeons at any one time) at the University
of Ottawa Heart Institute, during an 8-year study period from mid-2002 to
mid-2010. The OPCAB group includes 550 consecutive patients with cor-
onary artery disease who underwent first-time OPCAB during the same
study period, carried out by the 2 surgeons (of the same 10 aforementioned
CABG surgeons) who performed (and still perform) more than 25% of
their coronary bypass caseload off-pump (M.R. and F.D.R.). Patients
with cerebrovascular or peripheral vascular disease were preferentially re-
ferred to an OPCAB surgeon through the institutional central triage. The
ultimate decision to perform OPCAB surgery was made by the operating
surgeon considering patient preference, patient comorbidities, and coro-
nary anatomy. All elective, urgent, and emergency coronary bypass opera-
tions were included. Patients undergoing redo surgery or patients who
underwent concomitant procedures, such as valve repair or replacement,
aortic surgery, aneurysm resection, atrial fibrillation surgery, septal defect
closure, and others, were excluded from the study, unless the associated
procedure resulted from a complication of the index surgery.
Preoperative, operative, and postoperative data were prospectively
collected and simultaneously entered into 2 distinct and independent data-
bases, which overlap information and were cross-verified for the purposes
of the present study. Furthermore, both databases have been subjected to
regular quality audits for accuracy and completeness. All patient data
from the present study were de-identified and kept at the research premises;
as such, individual patient consent was waived.
Operative Management
The conducts of the on-pump CABG and OPCAB operations have been
extensively described.8 All procedures were performed via a median ster-
notomy incision. Patients undergoing on-pump CABG received heparin to
maintain their activated clotting time more than 480 seconds while on car-
diopulmonary bypass. During aortic crossclamping, antegrade or retro-
grade cardioplegia (using cold crystalloid from 2002 to 2004, and cold
blood after 2004) was intermittently administered at 20- to 30-minute inter-
vals. Patients undergoing OPCAB received intravenous heparin to maintain
the activated clotting time more than 250 seconds from the termination of
conduit harvest to the completion of all anastomoses.
Unless contraindicated, after OPCAB, patients were administered, on
the day of the operation, daily enteric-coated acetylsalicylic acid 81 mg
and clopidogrel 75 mg. Likewise, patients undergoing CABG received
enteric-coated acetylsalicylic acid 325 to 650 mg postoperatively, within
6 hours of termination of surgery, and the drug was continued at a dose
of 325 mg by mouth daily without clopidogrel. Unless contraindicated, an-
tihypertensives were resumed on the first postoperative day. Patients with
a radial artery graft were prescribed a benzodiazepine or dihydropyridine
calcium channel blocker for 6 months postoperatively.
No standardized postoperative hydration protocol was used in this study.
Intravenous fluids were administered to OPCAB and on-pump CABG86 The Journal of Thoracic and Cardiovascular Surgecases according to systolic blood pressure, urine output, echocardiographic
left ventricular filling, central venous pressure, pulmonary artery diastolic
or wedge pressure, body weight, and pulmonary function. Extubated
patients who had stable hemodynamic and renal indices were placed on
a diuretic protocol.Outcome Definitions
Patients were followed for a minimum of 30 days after discharge from
the hospital. Death was defined as mortality occurring in hospital at any
time during the index hospitalization or within 30 days of operation.
Perioperative myocardial infarction consisted of new Q-wave on 12-lead
electrocardiogram, creatine kinase-MB, or troponin-T or I elevation above
institutional cutoff criteria in effect at the time. Strokewas defined as a per-
manent new focal neurologic deficit occurring intra- or postoperatively,
with focal or lateralizing signs on physical examination and computed to-
mography confirmation.
With regard to renal outcomes, the preoperative creatinine level used
was the latest available laboratory result before surgery. The highest
postoperative creatinine corresponded to the highest level recorded postop-
eratively during the index surgical admission. The creatinine clearance was
calculated in a gender-specific manner by using the Cockcroft–Gault
formula.9 For both preoperative and postoperative creatinine clearance cal-
culations, the weight used corresponded to the last available weight before
surgery. The change in creatinine clearance was calculated by subtracting
the preoperative creatinine clearance from the postoperative creatinine
clearance. Patients who were receiving dialysis preoperatively were not in-
cluded in the reporting and analyses of preoperative creatinine, postopera-
tive creatinine, and creatinine clearance levels.Statistical Methods
For all analyses, the classification of on-pump CABG versus OPCAB
took place according to the intention-to-treat principle at the initiation of
proximal or distal anastomotic grafting. For instance, patients who were
converted fromOPCAB to on-pumpCABG before the initiation of grafting
are considered CABG cases, and those converted to CABG after the
initiation of proximal or distal grafting are considered OPCAB cases. All
conversions from OPCAB to CABG, with their cause, were prospectively
recorded.
Comparisons between the on-pump CABG and OPCAB groups were
carried out in Stata 11.2 (StataCorp, College Station, Tex). For each renal
outcome of interest, 3 types of analyses were performed: crude (ie, univari-
able), multivariable regression, and nearest neighbor matching. For univari-
able comparisons, the central limit theorem was assumed for continuous
variables, and these were examined by using an unpaired Student t test.
Categoric data were examined with a Fisher exact test. Multivariable com-
parisons of continuous and categoric renal outcomes used linear or logistic
regression, respectively, and included all of the following covariates simul-
taneously, without the use of an automated selection procedure: age, gender,
hypertension, body mass index (except for creatinine clearance outcomes),
cerebrovascular disease, peripheral vascular disease, diabetes mellitus,
Cardiac Anesthesia Risk Evaluation (CARE) score,10 left ventricular grade
(1–4),11 operative priority, and preoperative creatinine (except for creatinine
clearance outcomes). Finally, bias-corrected nearest neighbor matching es-
timations for the average treatment effect ofOPCABversus on-pumpCABG
on serum creatinine and creatinine clearance were performed, as described
by Abadie and Imbens.12 With the use of this technique, all observations
from the 5039 patients undergoing CABG were matched to their closest
matches in the opposite treatment group, namely, the 550 patients undergo-
ing OPCAB, by allowing each observation to be used as a match more than
once if necessary,with the order ofmatching being irrelevant; this, therefore,
provided an estimate of the counterfactual treatment outcome.
All results are reported according to the intent-to-treat principle. Con-
tinuous data are expressed as means standard deviation, unless specifiedry c January 2012
TABLE 1. Preoperative patient characteristics (N ¼ 5589)
CABG
(N ¼ 5039)
OPCAB
(N ¼ 550)
P
value
Age, y 64.8  9.9 66.6  10.8 <.001
BMI, kg/m2 28.7  5.0 27.7  4.9 <.001
Diabetes mellitus, n 1881 (37.3%) 175 (31.8%) .01
Hypertension, n 3921 (77.8%) 445 (80.0%) .1
Men/women, n 3980/1059 407/143 .009
Cerebrovascular disease, n 494 (9.8%) 91 (16.5%) <.001
Peripheral vascular disease, n 747 (17.4%) 134 (24.0%) <.001
Left ventricular grade,* n
I 3415 (67.7%) 394 (71.6%) .07
II 1032 (20.4%) 106 (19.2%)
III 482 (9.5%) 36 (6.5%)
IV 110 (2.1%) 4 (0.7%)
Operative priority, n
Elective 2676 (53.3%) 316 (57.4%)
Urgent 2092 (41.5%) 221 (40.1%) .002
Emergency  24 h 112 (2.2%) 9 (1.6%)
Immediate 159 (0.3%) 4 (0.7%)
CARE score
1 373 (7.4%) 43 (7.8%)
2 2947 (58.4%) 308 (56.0%) .1
3 1632 (32.3%) 181 (32.9%)
4 18 (0.3%) 3 (0.5%)
5 69 (1.3%) 15 (2.7%)
Preoperative Cr (mg/dL) 1.14  0.56 1.27  1.00 <.001
Preoperative CrCl (mL/min) 82.8  32.5 74.8  32.7 <.001
Preoperative dialysis, n 49 (1.0%) 15 (2.7%) .001
BMI, Body mass index; CARE, Cardiac Anesthesia Risk Evaluation; Cr, creatinine;
CrCl, creatinine clearance. *Left ventricular grade I¼ ejection fraction>50%, grade
II ¼ ejection fraction 35%–50%, grade III ¼ ejection fraction 20%–4%, grade
IV ¼ ejection fraction<20%.
TABLE 2. Operative characteristics and postoperative results
(N ¼ 5589)
CABG
(N ¼ 5039)
OPCAB
(N ¼ 550)
P
value
No. of grafts (mean) 2.8  0.6 2.2  0.7 <.001
Conversion to CPB, n 5 12 n/a
Before grafting, n 5 (2.7%)* (n/a)*
Instability during grafting, n n/a 7
Difficult graftability, n n/a 4
Other, n n/a 1y
Return to operating room, n 233 (4.6%) 20 (3.6%) .3
Perioperative MI, n 100 (2.0%) 10 (1.8%) .9
Renal outcomesy
Highest postoperative Cr (mg/dL) 1.28  0.77 1.52  1.29 <.001
Lowest postoperative
CrCl (mL/min)
77.3  31.5 67.7  32.0 <.001
Change in Cr (mg/dL) 0.14  0.21 0.25  0.29 .001
Change in CrCl (mL/min) 5.0  15.5 6.3  14.1 .06
De novo postoperative dialysis, n 104 (2.1%) 14 (2.6%) .4
Stroke, n 42 (0.8%) 2 (0.4%) .3
Median length of stay, d 8 8 .8
Death, n 87 (1.7%) 8 (1.5%) .9
CPB, Cardiopulmonary bypass; Cr, creatinine; CrCl, creatinine clearance; MI, myo-
cardial infarction; n/a, not applicable. *Allocation of CABG vs OPCAB took place
according to the intention-to-treat principle, before the initiation of proximal or distal
grafting. Patients who were converted from OPCAB to CABG before the initiation of
grafting are considered CABG cases; patients converted to CABG after the initiation
of proximal or distal grafting are considered OPCAB cases. yExclude patients on
dialysis preoperatively.
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tests were 2-tailed, and statistical significance was set at P<.05.RESULTS
The cohort‘s mean age was 64.9  10.0 years, and 4378
patients were male (78.5%). Compared with patients under-
going on-pump CABG, Table 1 shows that patients under-
going OPCAB were older (66.6  10.8 years vs 64.8 
9.9 years, P<.001) and more commonly had cerebrovascu-
lar (16.5% vs 9.8%, P< .001) and peripheral vascular
disease (24.0% vs 17.4%, P<.001) (Table 1). Patients un-
dergoing OPCAB also had a higher preoperative creatinine
level (1.27  1.00 mg/dL vs 1.14  0.56 mg/dL, P<.001)
and a lower preoperative creatinine clearance (74.8  32.7
mL/min vs 82.8  32.5 mL/min, P<.001). Patients under-
going OPCAB received fewer coronary grafts compared
with patients undergoing on-pump CABG (2.2  0.7 grafts
vs 2.8  0.6 grafts, P<.001).
Seventeen patients undergoing OPCAB were converted
to on-pump CABG in this series (Table 2): Five conversions
occurred before grafting was initiated and are therefore con-
sidered as CABG. Of the 12 conversions that occurred afterThe Journal of Thoracic and Cthe initiation of grafting (considered OPCAB in the analy-
ses), 4 were due to difficulty in grafting, 7 were due to he-
modynamic instability, and 1 was due to an aortic dissection
during tangential clamping with a side-biting clamp, which
was successfully repaired on pump with circulatory arrest.
There was no significant difference between the 2 groups
with respect to rates of mortality, postoperative stroke, myo-
cardial infarction, return to the operating room, and ICU or
hospital length of stay.
Univariable crude analyses indicated that OPCAB was
postoperatively associated with a higher serum creatinine
(1.52 1.29 mg/dL vs 1.28 0.77 mg/dL, P<.001), lower
creatinine clearance (67.7  32.0 mL/min vs 77.3  31.5
mL/min, P<.001), and greater increase in serum creatinine
preoperatively to postoperatively (0.25  0.29 vs 0.14 
0.21, P ¼ .001) compared with on-pump CABG
(Table 2). However, unadjusted analyses did not show a sig-
nificant statistical difference between the 2 groups in the
change in creatinine clearance preoperatively to postopera-
tively (P ¼ .06) or in the need for de novo postoperative
dialysis (P ¼ .4).
On multivariable analyses, linear regression models in-
clusive of all terms enumerated in Table 3 showed that older
age, female gender, higher body mass index, higher creati-
nine preoperatively, peripheral vascular disease, operative
priority, higher CARE score, and OPCAB (vs CABG)ardiovascular Surgery c Volume 143, Number 1 87
TABLE 3. Multivariable predictors of renal outcomes
Change in Cr
(weighted effect ± SE; mg/dL)
Change in CrCl
(weighted effect ± SE; mL/min)
De novo postoperative
dialysis (OR ± SE)
Age, per year 0.002  0.004 (<0.001)* 0.003  0.02 (0.9) 1.05  0.01 (<0.001)*
BMI, per kg/m2 0.008  0.009 (<0.001)* 0.69  0.04 (<0.001)* 1.06  0.02 (0.001)*
Cerebrovascular disease, if present 0.011  0.001 (0.4) 0.04  0.69 (0.9) 1.8  0.5 (0.03)*
Diabetes mellitus, if present 0.012  0.009 (0.2) 0.81  0.43 (0.06)* 2.4  0.5 (<0.001)*
Female gender, if present 0.033  0.010 (<0.001)* 3.5  0.5 (<0.001)* 1.5  0.3 (0.07)
Hypertension, if present 0.022  0.011 (0.04)* 2.0  0.5 (<0.001)* 1.2  0.4 (0.6)
Peripheral vascular disease, if present 0.052  0.012 (<0.001)* 1.7  0.6 (0.003)* 1.4  0.3 (0.2)
Preoperative Cr, per mg/dL 0.048  0.012 (<0.001)* 10.2  0.6 (<0.001)* 1.5  0.1 (<0.001)*
Left ventricular grade, per grade increase 0.020  0.005 (<0.001)* 0.75  0.28 (0.007)* 1.2  0.1 (0.1)
Operative priority, per unit increase 0.028  0.006 (<0.001)* 1.4  0.3 (<0.001)* 1.9  0.2 (<0.001)*
CARE score, per unit increase 0.049  0.007 (<0.001)* 2.1  0.4 (<0.001)* 1.6  0.2 (0.001)*
Surgeony 3.87–5.88 (0.001)* 3.21 to2.23 (<0.001)* 0.64–1.19 (0.7)
OPCAB vs CABG 0.05  0.014 (<0.001)* 2.6  0.6 (<0.001)* 0.9  0.3 (0.8)
CARE, Cardiac Anesthesia Risk Evaluation; Cr, creatinine; CrCl, creatinine clearance; SE, standard error. P values are shown in parentheses below the mean effect or odds ratio.
*Statistically significantP value. yRange of coefficients when considering exclusion of any one of the 10 different surgeons in separate multivariable models. The lowest P value is
shown in parentheses.
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a greater decrease in creatinine clearance postoperatively.
However, there was no independent impact of performing
OPCAB versus on-pump CABG on the need for de novo
dialysis postoperatively, as revealed by logistic regression.
When comparing matched OPCAB and on-pump CABG
cases by using a nearest neighbor matching method, OP-
CAB remained associated with a greater increase in postop-
erative creatinine (by 0.05  0.02 mg/dL, P ¼ .007) and
a greater decrease in creatinine clearance (by2.1  0.8
mL/min, P ¼ .007) postoperatively, when compared with
CABG (Table 4).
Finally, when the independent effects of OPCAB versus
CABG on renal outcomes were analyzed according to 4
classes of preoperative renal function (Figure 1), there
was no trend suggestive of either therapy being significantly
better than the other within threshold-specific levels of
preexisting renal function.DISCUSSION
Postoperative renal dysfunction is a common and serious
complication of cardiac surgery. It is associatedwith a longerTABLE 4. Nearest neighbormatching estimationof effects ofoff-pump
versus on-pump coronary artery bypass on postoperative renal
indices*
Weighted effect ± SE of
OPCAB vs CABG 95% CI P value
Change in Cr (mg/dL) 0.05  0.02 0.01–0.08 .007
Change in CrCl (mL/min) 2.1  0.8 3.7 to0.6 .007
CI, Confidence interval; Cr, creatinine; CrCl, creatinine clearance; SE, standard error.
*The bias-adjusted variables used for nearest neighbor matching were preoperative
creatinine level, age, body mass index, and operative priority. The variables used
for exact matching were gender, cerebrovascular disease, peripheral vascular disease,
left ventricular grade, diabetes mellitus, hypertension, and CARE score.
88 The Journal of Thoracic and Cardiovascular Surgeintensive care unit and hospital stay in addition to a higher
perioperative mortality.13-16 Emerging evidence suggests
that even small increases in serum creatinine after cardiac
surgery may be associated with poorer survival.17
Several preoperative risk factors have been associated
with an increased risk of acute renal failure after CABG.
These include female gender, advanced age, reduced left
ventricular function or presence of congestive heart failure,
diabetes mellitus, peripheral vascular disease, the need for
emergency surgery, and elevated preoperative serum creat-
inine.18,19 Intraoperative risk factors for acute renal injury
include prolonged cardiopulmonary bypass and aortic
crossclamp times13; in this regard, inadequate or nonpulsa-
tile renal perfusion, macro- and microembolic loads on the
renal vasculature, and the inflammatory response to cardio-
pulmonary bypass have all been implicated as potential
etiologic factors for postoperative renal dysfunction and
renal failure.4,13
Although OPCAB removes some of the intraoperative
risk factors associated with cardiopulmonary bypass, the
relative benefits of OPCAB on renal function have been
a controversial issue in the cardiac surgical literature.4-6,20
The present study reveals that OPCAB is not protective of
renal function and seems to be associated with a small,
but statistically significant increase in postoperative
serum creatinine and decrease in creatinine clearance.
The development of renal dysfunction after CABG is
multifactorial, and many perioperative factors that may
lead to renal dysfunction are independent of the technique
of revascularization. Although the patients undergoing
OPCAB in our study presented more risk factors for the
development of renal dysfunction than those undergoing
on-pump CABG, the independent response to OPCAB
also trended toward being unfavorable. It is possible thatry c January 2012
FIGURE 1. Effects of OPCAB versus on-pump CABG on renal outcomes
according to the degree of preoperative renal dysfunction. The weighted
effect and confidence interval for the change in serum creatinine (A) and
creatinine clearance (B) preoperatively to postoperatively. C, Odds ratio
and confidence interval of postoperative dialysis in patients who were
not requiring dialysis preoperatively. yP<.05. OPCAB, Off-pump coro-
nary artery bypass; CABG, coronary artery bypass grafting.
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use of anesthetic drugs, different vasoactive and inotropic
medications used, and lesser perioperative intravenousThe Journal of Thoracic and Cvolume loading in OPCAB versus on-pump CABG cases
may make the former group more at risk of subclinical
nephrotoxicity, beyond the advantages expected to be
conferred by the avoidance of cardiopulmonary bypass.
Furthermore, the use of a cell saver device, suctioning-
based stabilizers, and other off-pump tools may inherently
induce some degree of inflammatory response.21 OPCAB
may induce short, transient periods of hypoperfusion
that compromise both cardiac output and renal perfusion
during exposure of target vessels, which could be a contrib-
uting factor in the development of postoperative renal
failure.4,13,22
Previous Related Work
Our results are in agreement with those of Asimakopou-
los and colleagues,23 in their retrospective study of 704 con-
secutive patients. Of these patients, 404 had undergone
OPCAB and 300 had undergone on-pump CABG. These
authors found no statistically significant difference in post-
operative hemodialysis rates between groups and noted
similar postoperative changes in creatinine clearance.
Tang and colleagues24 prospectively randomized 40 low-
risk patients with normal preoperative cardiac and renal
functions awaiting elective CABG. They found significant
and similar levels of injury to renal tubules and glomeruli
after OPCAB or CABG.24 In a retrospective study that in-
cluded 690 patients undergoing primary elective coronary
bypass (OPCAB, N ¼ 55; CABG, N ¼ 635), Gamoso and
colleagues5 did not find that OPCAB significantly reduced
perioperative renal dysfunction compared with CABG. In
a meta-analysis of 37 randomized trials (3369 patients) of
OPCAB versus CABG performed by Cheng and col-
leagues,3 there was no significant difference between the
2 techniques regarding renal dysfunction. In a retrospective
study of 2943 patients with multivessel surgical coronary
disease, Di Mauro and colleagues25 found that OPCAB
may play a renoprotective role and provides better early
and late outcomes in patients with normal preoperative
creatinine; however, when the preoperative creatinine was
abnormal, the surgical strategy did not seem to have any in-
fluence, and the occurrence of renal failure impaired early
and long-term mortality equally, regardless of choice of
operative strategy. In a randomized trial that included
2203 patients scheduled for elective or urgent CABG and
randomized to CABG or OPCAB, Shroyer and colleagues26
found no statistical significant benefit of OPCAB on renal
end points. OPCAB had a worse composite outcome
incidence than CABG with respect to all-cause mortality,
repeat revascularization, or nonfatal myocardial infarction
at 1 year follow-up. Ascione and colleagues27 and Loef
and colleagues28 reported that OPCAB has renal protective
effects, but although their studies were prospective, they
included only a small number of healthy patients without
renal impairment or major comorbidities.ardiovascular Surgery c Volume 143, Number 1 89
Acquired Cardiovascular Disease Elmistekawy et al
A
C
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randomized controlled trials, with a total number of patients
of 4819, Seabra and colleagues7 reported that when com-
pared with CABG, OPCAB was associated with 40% lower
odds for postoperative acute renal injury (P ¼ .003) and
a nonsignificant 33% reduction in the odds of requiring
dialysis; OPCABwas not associated with a decrease inmor-
tality. Although this meta-analysis included 22 trials, it is
limited by the following factors: heterogeneous definitions
of acute renal injury (some trials did not describe the criteria
used for definition of acute renal injury), more than half of
these trials included less than 100 patients, none of these tri-
als included emergency revascularization (most of the trials
even did not include urgent operations), and the trials did
not routinely report comorbidities. Furthermore, when
excluding the smaller trials (with the highest reported inci-
dence of renal injury) from this meta-analysis, the statistical
significance of the pooled acute renal injury outcome was
lost.Limitations
Although the present study is a large series involving pro-
spectively collected data on all patients who met inclusion
criteria for analysis at our center, it still has the limitation
of being a retrospective analysis and a single-center experi-
ence. All efforts were made to account for confounders, but
it is also possible that unsuspected comorbidities, institu-
tional, technical, or biological factors may have influenced
results. For example, the renal responses to surgery may
have been exaggerated in patients with more comorbidities.
Because these patients also tended to undergo OPCAB sur-
gery, effect modification may be observed. Also, patients
undergoing OPCAB had fewer coronary grafts than those
undergoing on-pump CABG, which is in keeping with pre-
vious work.26 Although no difference in the incidence of
perioperative myocardial infarction, perioperative stroke,
prolonged hospital stay, or death was observed between
groups, the difference in the number of grafts is important.
As such, the number of coronary grafts was included as
a covariate in each of the multivariable models.CONCLUSIONS
Notwithstanding the aforementioned limitations, our
study reveals, in a large cohort, that OPCAB does not pre-
serve renal function to a greater extent than on-pump
CABG. In fact, a trend to the reverse exists with no clini-
cally harmful effects. On the basis of these findings,
although there may be several other benefits of performing
OPCAB in some patients, we believe that improved renal
preservation compared with CABG does not seem to consti-
tute one of them, and that more research as to the mecha-
nism explaining this lack of protective effect, as well as90 The Journal of Thoracic and Cardiovascular Surgetoward possibly overcoming it with renal protective strate-
gies or adjuvants, is warranted.References
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DDiscussion
Dr Marc Moon (St Louis, Mo). The on-pump versus off-pump
debate has been going on for more than a decade, and we really
aren’t reaching any resolution anytime soon. Although your study
demonstrated no difference in the incidence of renal dysfunction,
there was a study yesterday [Presented by Lemma M, et al.
On-pump vs off-pump coronary artery bypass surgery in high-
risk patients: operative results of a prospective randomized trial
(on-off study).] that showed the opposite result, and I think most
of the studies have been one way or the other and haven’t come
to a strong conclusion.
I am always impressed when I show up in the intensive care unit
the day after surgery and see 2 patients in 2 beds next to each other,
and you can’t tell which one had off-pump and which one had on-
pump surgery. The only consistent finding in most of the studies
has been a decrease in the transfusion requirements in off-pump
surgery, although in a center that uses strict blood conservation
techniques, the difference may be fairly minimal.
I would like to ask you a couple of questions about your study.
One is this matching technique that you used. You didn’t really
give us much detail on that. That is a bit usual; it wasn’t a propen-
sity match. Maybe you can get a bit into the statistical analysis of
that.
Second, your OPCAB cases were substantially sicker, it ap-
peared, than the on-pump CABG cases. Do you think the matching
or the multivariate analysis you used can really tease out robustly
the differences that may be intrinsic in those 2 different groups of
patients?
On thebasis of yourfindings,what techniquedoes your center rec-
ommend for these patients undergoing off-pump versus on-pump
surgery, and does it depend on the subgroup of patientswho is under-
going operation or is it just surgeon dependent on what he or she is
most comfortable which, which is what my feelings are?
Dr Elmistekawy. In response to your first question, we used
a bias-corrected nearest neighbor matching estimation for averageThe Journal of Thoracic and Ctreatment. This technique has been mostly used in economics, and
the 5309 patients undergoing on-pump CABG were matched clos-
est to matches in the opposite treatment group, namely, the 550 pa-
tients undergoing OPCAB, by allowing each observation to be
used as a match more than once if necessary, with the order of
matching being irrelevant; this, therefore, provided an estimate
of the counterfactual treatment outcome. It is important to note
that some variables were specified in the model to be matched ex-
actly, such as gender, cerebrovascular disease, and left ventricular
grade, whereas others, such as age, body mass index, and preoper-
ative creatinine, were matched to their nearest neighbor. We think
that is used in economics with good validity, and it can also give us
a good idea about the average treatment with bias correction.
For your second question, yes, this study included sicker patients
undergoing OPCAB, and these sicker patients may have had a dif-
ferent biological response to perioperative stress and bemore prone
to have renal dysfunction after surgery. Butwe did both amultivari-
able regression analysis and thismatching analysis, trying to get out
all of the confounders, by including all of the major factors that can
affect the renal outcome in those patients.
In our center, the choice of on-pump versus off-pump technique
is influenced by many factors: number one, patient characteristics,
such as the presence of ascending aortic disease and coronary anat-
omy; number two, patient preference, such as if the patient asks for
OPCAB, or the cardiologist referral, which also is a factor in the
selection of on-pump CABG versus OPCAB.
Dr Moon. We can safely conclude that these days the most
appropriate thing is for the surgeon to do the operation he or she
is most comfortable with.
Dr Lokeswara Sajja (Hyderabad, India). I congratulate
Dr Elmistekawy for a good presentation, and I have a comment
to make and a couple of questions to ask. We are one of the earlier
groups to conduct a randomized study on the effect of off-pump and
on-pump techniques in patients with preoperative nondialysis-de-
pendent renal insufficiency undergoing CABG, and our study
proved that the off-pump technique is renoprotective in patients
with nondialysis-dependent renal insufficiency. As we all know,
approximately 15% to 20% of the patients undergoing CABG
have occult renal dysfunction, meaning they have normal serum
creatinine levels (ie, 1.3 mg/dL) in association with decreased
glomerular filtration rate (ie,<60 mL/min/1.73 m2 body area).
In this study, as you have presented, there is a statistically
significant difference in the preoperative serum creatinine levels
between the off-pump and on-pump groups. In the OPCAB group,
the mean serum creatinine level is 1.3 mg/dL, and in the on-pump
CABGgroup, the serum creatinine level is 1.0mg/dL. Even a small
increase in the preoperative serum creatinine also has a deleterious
effect on the postoperative incidence of acute kidney injury.
My question to you is, did you routinely estimate the glomerular
filtration rate in these patients? The other question is, what
percentage of these patients received aprotinin during their perio-
perative period to control bleeding?
Dr Elmistekawy. I am sorry, I didn’t get your questions.
Dr Sajja. Did you estimate creatinine clearance in these
patients? If so, what percentage of the patients in each group
had occult renal disease?
Dr Elmistekawy. We did creatinine clearance estimation for
the purpose of this study, but otherwise it wasn’t routinely done.ardiovascular Surgery c Volume 143, Number 1 91
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DDr Sajja. Did more patients receive aprotinin in the OPCAB
group?
Dr Elmistekawy. I am sorry, I didn’t get the question.
Dr Sajja. Is there any difference in the use of aprotinin between
the 2 groups?
Dr Elmistekawy. Aprotinin.
Dr Sajja. Use of aprotinin between the 2 groups?
Dr Elmistekawy. We didn’t examine this.
Dr Marc Ruel (Ottawa, Ontario, Canada). Perhaps I could in-
tervene. My name is Marc Ruel; I am the senior author of this
study. Aprotinin was not used at all in this series except for excep-
tional cases, for instance, patients receiving clopidogrel during
emergency cases, in the old times.
I would like to comment on the findings and respond to some of
the excellent questions that have been raised. First, I am an off-
pump enthusiast and believer. When we started this study, we
thought we would actually prove once and for all, in a series
with large numbers and good outcomes, that OPCAB is better
than CABG on the kidney. Actually, we were surprised to find
the complete reverse, in that there was no outcome difference,
not only at the univariate level but also at 2 levels of multivariable
analysis, even when accounting for preoperative differences in
renal function and for comorbidities.
So from this we can think, why do we have those findings?
I think Elsayed alluded to the possible institutional or technical
factors that may have caused this lack of difference, and one of
those factors may be the extra fluid load that patients undergoing
CABG receive. A patient undergoing CABG typically comes out
of the operating room with 4 or 5 extra kilos of fluid, and that
may in itself be renal protective. On the other hand, we don’t
have this extra fluid load in OPCAB cases. In addition, OPCAB
cases have more ups and downs in terms of their cardiac output
during the procedure. They may have short periods of inotrope
use, especially when grafting the lateral wall.92 The Journal of Thoracic and Cardiovascular SurgeFurthermore, maybe one of the reasons we don’t see a difference
in this study while smaller studies have shown opposite results is
that the event rates were overall very low. The results of on-
pump CABG and OPCAB in this study, even if when including
all emergencies, and patients in cardiogenic shock, and patients
coming from the catheter laboratory, were very good. So these re-
sults clearly show that the perfusion teamdoes an excellent jobwith
those usual, short 1-hour cardiopulmonary bypass time periods
needed to do 3 or 4 grafts. Well, with those as a typical, routine
case, it is hard to show a difference between off-pump and on-
pump on the renal outcomes. With this, I would like to acknowl-
edge the excellent questions and comments that have been raised,
and thank the Association for the honor of presenting these data.
Dr Massimo Lemma (Milano, Italy). One comment and one
question. The comment is that we had a completely different expe-
rience. Yesterday I presented the primary end point of the ON-OFF
study, where we compared 30-day outcomes of high-risk patients
with a euroSCORE greater than 6 after on-pump CABG or
OPCAB. In our study, the intention-to-treat analysis showed that
there is an advantage for these patients in terms of renal failure,
even if not statistically significant, but it became statistically signif-
icant after on-treatment analysis, that is, after consideration of
crossovers.
The question is related to what you do to maintain hemody-
namic stability during the operation. Could you precisely tell us
the anesthetic and surgical management of the patient during
OPCAB to maintain hemodynamic stability and if you check the
cardiac output during the operation?
Dr Elmistekawy. You are right, during exposure, especially
of the lateral wall, there is a period of low cardiac output or
hypoperfusion, and we optimize this by using vasoactive drugs
(eg, norepinephrine) and volume loading, with interruption of
the procedure until the blood pressure and the cardiac output
are optimized.ry c January 2012
